OPGN – Opgen Inc
Float Short %
1.02
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
4.7
Target Price
Analyst Recom
3
Performance Q
-57.39
Relative Volume
Beta
-0.64
Ticker: OPGN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-18 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-19 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-20 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-21 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-22 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-25 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-26 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-27 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-28 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-08-29 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-02 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-03 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-04 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-05 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-08 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-09 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-10 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-11 | OPGN | 0.0001 | N/A | N/A | 0 |
| 2025-09-12 | OPGN | 0.0001 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | OPGN | 4.70 | - | - | -10.37 |
| 2025-08-18 | OPGN | 4.70 | - | - | -10.37 |
| 2025-08-19 | OPGN | 4.70 | - | - | -10.37 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
No data found
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.13
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
Beta
-0.64
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
17
Growth Score
25
Sentiment Score
67
Actual DrawDown %
99.5
Max Drawdown 5-Year %
-99.9
Target Price
P/E
Forward P/E
PEG
P/S
6.13
P/B
P/Free Cash Flow
EPS
-40.32
Average EPS Est. Cur. Y
-10.37
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
Return on Equity vs Sector %
-356.7
Return on Equity vs Industry %
-350.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-4.18
EBIT Estimation
OpGen, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 1
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
stock quote shares OPGN – Opgen Inc Stock Price stock today
news today OPGN – Opgen Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch OPGN – Opgen Inc yahoo finance google finance
stock history OPGN – Opgen Inc invest stock market
stock prices OPGN premarket after hours
ticker OPGN fair value insiders trading